Request Speaker Information
Speakers and Panels
Benjamin Smith
Executive Director and President
Monell Chemical Senses Center
Janice Wong
COO
Gattuso Development Partners
Katie Reuther
Executive Director
Penn Health-Tech
Peter Scarpati
VP, Operations
The Wistar Institute
Zev Sunleaf
Vice President, Technology Transfer, Commercialization, and Research Contracts
CHOP
Pete Cramer
Market Executive, VP, Development
Wexford Science + Technology
why you should attend the philadelphia life sciences & innovation summit
Why This Matters
Greater Philadelphia’s life sciences market is entering a more selective and consequential phase. CBRE reported that two major leases totaling more than 360K SF represented all of the region’s life sciences leasing during Q1 2026, while newly available inventory contributed to occupancy losses. At the same time, early-year funding activity offered a potential signal that investor confidence may be beginning to improve.
The region is also attracting investments that extend its economy beyond research and into company formation, specialized production and commercial-scale manufacturing. Johnson & Johnson announced plans to invest more than $1B in a Montgomery County cell therapy facility expected to support 500 permanent biomanufacturing jobs, Legend Biotech opened a 31K SF Philadelphia R&D center, and Penn, BioNTech and Osage University Partners launched a $50M fund for early-stage companies spun out of Penn.
These contrasting forces are creating important decisions for owners, developers, investors and occupiers. Where is demand actually emerging? Which properties can compete for today’s tenants? What will it take for companies to remain and expand in the region? And how can Greater Philadelphia convert its scientific discoveries into sustained real estate demand, investment and job growth?
What You’ll Learn
Where laboratory, incubator, R&D and specialized manufacturing demand is emerging across Philadelphia and its surrounding suburbs
How owners are adjusting leasing strategies, tenant improvements, flexible-space offerings and speed-to-occupancy requirements
What investors, lenders and developers need to see before funding acquisitions, repositioning projects or new construction
Which factors determine whether early-stage companies remain in Greater Philadelphia as they raise capital and require larger facilities
How research institutions, pharmaceutical partnerships and new investment funds are influencing company formation and commercialization
What infrastructure, utilities, workforce pipelines and public incentives are required to attract advanced manufacturing users
Which leasing, funding and development indicators would signal the beginning of a stronger regional growth cycle
How You’ll Do More Business
Connect with the owners, developers, investors, biotech executives, research leaders and public-sector decision-makers determining where companies locate, which facilities receive capital and how projects move forward. Attendees will gain direct insight into active space requirements, emerging development opportunities and the partnerships companies need as they advance from research through commercialization.
The event will bring together organizations working across laboratory real estate, venture capital, construction, engineering, manufacturing, economic development and company operations, creating opportunities to identify clients, project partners, tenants, capital sources and specialized service providers throughout the regional ecosystem.
Who Attends
Owners, developers, investors, lenders, biotech and pharmaceutical executives, laboratory and manufacturing occupiers, venture capital firms, research institutions, healthcare systems, economic development agencies, brokers, architects, engineers, contractors, project managers, property managers, attorneys, consultants and specialized service providers supporting Greater Philadelphia’s life sciences economy.
Why You Should Attend
Philadelphia has the scientific talent and institutional foundation to remain a major life sciences market, but the next phase of growth will depend on how effectively the region connects capital, companies, real estate and manufacturing. Attend to understand where activity is gaining traction, how decision-makers are navigating a more selective market and where new business opportunities are likely to emerge.
Agenda
| Time | Activity |
|---|---|
|
8:00 AM
9:00 AM
|
Registration, Networking & Breakfast
|
|
9:00 AM
9:45 AM
|
Philadelphia Life Sciences Real Estate: Reading the Current Market
Examining existing lab inventory, vacancy, leasing activity, development and conversions—and how owners and investors are underwriting risk today |
|
9:45 AM
10:30 AM
|
Building Philadelphia’s Life Sciences Economy: From Discovery to Growth
How emerging companies, commercialization, manufacturing, talent and capital will shape the region’s next phase of growth and future space demand |
|
10:30 AM
10:45 AM
|
Networking Break
|
|
10:45 AM
11:30 AM
|
The Science of the Build: Designing and Delivering Philadelphia’s Life Sciences Facilities
How occupiers, developers, architects, engineers and contractors are controlling cost and speed-to-market while creating flexible labs, cleanrooms and specialized production environments that can adapt to changing science, equipment and regulatory requirements |
|
11:30 AM
12:00 PM
|
Closing Networking
|
Tickets
Super Early Bird
$120.00 /ticket
Our best price. Only 12 tickets available at this rate.
PS - Want the attendee list for free?
Biscred gives you a complimentary 1-week trial with 250 credits to search 6M+ commercial real estate contacts — filter by asset class, job seniority, metro, property count, and more. Book a demo today and we'll activate your free trial when you mention this promotion.